PATENT CLAIM ANALYSIS

Application Number: 16355511
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "653000"]

Abstract:
Provided herein are epinephrine spray formulations. Also provided herein are methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatment.

Claim (Index 4):
The method of  claim 1 , wherein the subject exhibits one or more symptoms chosen from: respiratory depression or distress, airway constriction, wheezing, tingling hands, feet, mouth, or scalp, shortness of breath, swelling or inflammation of the face, eyes, lips, tongue, or throat, hives, central nervous system depression, cardiovascular depression, altered level consciousness, mydriatic pupils, hypoxemia, hypotension, unresponsiveness to stimulus, unconsciousness, stopped breathing, erratic or stopped pulse, and vomiting.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16355525', '16023313', '15488712', '13929100', '10607571']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7822167330103591
- 35 USC 102 Novelty (BERT): 0.5563480288324755
- Combined Prediction Score: 0.7596298625925707
- Mean Citation Score: 287.0916
- Max Citation Score: 447.93402
- Similarity Product: 351.59604521502257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test